Whalegun
Home

Gwenn Hansen, Chief Scientific Officer: Nurix Therapeutics NRIX Sell · Filed 25/01/30

Trade details

Type
Insider sale
Amount
$66,502.17
Shares · price
3,357 sh · $19.81 a share
Held after
56,270 sh
Stock
Nurix Therapeutics NRIX
Person
Gwenn HansenChief Scientific Officer
Trade date
25/01/30
Filed
25/01/30
Days to filing
0 days

Sold 5.6% of holdings

Share of holding sold
5.6%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/31~25/03/01

Gwenn Hansen's recent trades

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $215.1K

    Filed 08/05

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $95.5K

    Filed 08/04

  • Gwenn Hansen

    Sell10b5-1 planNurix Therapeutics

    $107.9K

    Filed 06/25

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $104.1K

    Filed 06/25

  • Gwenn Hansen

    SellNurix Therapeutics

    $53.5K

    Filed 04/30